SCHEMBL7920975

SCHEMBL7920975

CC(C)(C)[N+]([O-])=Cc1ccc(F)cc1C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
IDO1 P14902 2/20 0.35
ARNT P27540 1/20 0.33
EPAS1 Q99814 1/20 0.33
KCNH2 Q12809 1/20 0.33
HCAR1 Q9BXC0 1/20 0.33
APP P05067 1/20 0.31
PGR P06401 1/20 0.31
CYP3A4 P08684 1/20 0.31
AR P10275 1/20 0.31
ADORA2A P29274 1/20 0.31
HSD11B1 P28845 1/20 0.30
MAPT P10636 2/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7923573 0.81 NFE2L2 (0.42) KCNH2
SCHEMBL7921446 0.79 ALDH1A1 (0.36) ALDH1A1MEN1KMT2AARNTEPAS1
SCHEMBL7922778 0.78 NFE2L2 (0.42) ALDH1A1MAPTALOX15TSHRRECQL
SCHEMBL7922797 0.76 HTR2A (0.39) ALDH1A1KCNH2AR
SCHEMBL3315926 0.75 IDO1 (0.43) KMT2AIDO1KCNH2HCAR1APP
SCHEMBL7923555 0.74 GAA (0.38) ALDH1A1MEN1KMT2AIDO1KCNH2
SCHEMBL30619993 0.70 APP (0.42) IDO1KCNH2HCAR1APPADORA2A
SCHEMBL17489479 0.70 APP (0.42) IDO1KCNH2HCAR1APPADORA2A
SCHEMBL29110157 0.70 APP (0.42) IDO1KCNH2HCAR1APPADORA2A
SCHEMBL15216500 0.70 ALDH1A1 (0.48) ALDH1A1MAPTALOX15TSHRRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194461-B1 USEFUL AS MEDICAMENT FOR TREATING RETINAL DEGENERATIVE DISORDERS; ALPHA-(2,4-DIFLUOROPHENYL)-N-T-BUTYLNITRONE, AND CORRESPONDING AMINES WHICH WOULD BE CONVERTED IN VIVO TO THE NITRONE, FOR EXAMPLE SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-02-27 US disclosed
EP-0945426-A1 NITRONE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1999-09-29 EP disclosed